A case report of individualized treatment of high risk and volume metastatic prostate cancer
10.3760/cma.j.cn112330-20210405-00005
- VernacularTitle:个体化综合治疗高危/高肿瘤负荷转移性前列腺癌一例报告
- Author:
Yue MI
1
;
Kaiwei YANG
;
Qi TANG
;
Wei YU
;
Yi SONG
;
Zhisong HE
Author Information
1. 北京大学第一医院泌尿外科 北京大学泌尿外科研究所 国家泌尿男生殖系肿瘤研究中心 100034
- Keywords:
Prostatic neoplasms;
Metastatic;
Hormone-sensitive;
Castration-resistant;
Comprehensive therapy
- From:
Chinese Journal of Urology
2021;42(Z1):19-23
- CountryChina
- Language:Chinese
-
Abstract:
A 69-year old man presented with high-risk metastatic prostate cancer. After 7 months of androgen deprivation therapy (ADT), he progressed to metastatic castration resistant prostate cancer. We suggested him comprehensive therapy, including Abiraterone, chemo-therapy, radio-therapy, platinum chemo-therapy and Enzalutamide, which proved effective with his long term survival.
